Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat

Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis

(2010) V L Albaugh et al.   MOLECULAR PSYCHIATRY

A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model

(2010) Heidi N. Boyda et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Preclinical models of antipsychotic drug-induced metabolic side effects

(2010) Heidi N. Boyda et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model

(2009) Araba F. Chintoh et al.   SCHIZOPHRENIA RESEARCH

Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: Implications for glucose metabolism and food choice behaviour

(2009) Greg C. Smith et al.   SCHIZOPHRENIA RESEARCH

Abnormalities in Glucose Metabolism in Patients with Schizophrenia Treated with Atypical Antipsychotic Medications

(2008) Alan N. Elias et al.   AMERICAN JOURNAL OF MEDICINE

Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat

(2008) G. C. Smith et al.   DIABETOLOGIA

Modulation of taste sensitivity by GLP-1 signaling

(2008) Yu-Kyong Shin et al.   JOURNAL OF NEUROCHEMISTRY

Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway

(2008) R R Girgis et al.   MOLECULAR PSYCHIATRY

Differential Effects of Various Typical and Atypical Antipsychotics on Plasma Glucose and Insulin Levels in the Mouse: Evidence for the Involvement of Sympathetic Regulation

(2008) Y. E. Savoy et al.   SCHIZOPHRENIA BULLETIN

The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance

(2008) Kirsten Lykkegaard et al.   SCHIZOPHRENIA RESEARCH

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology

(2008) R TANDON et al.   SCHIZOPHRENIA RESEARCH

Glucose abnormalities in the siblings of people with schizophrenia

(2008) Emilio Fernandez-Egea et al.   SCHIZOPHRENIA RESEARCH

Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?

(2008) S SENGUPTA et al.   SCHIZOPHRENIA RESEARCH

Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in α2A-adrenoceptor knockout mice

(2007) Eriika Savontaus et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: Implications for animal models of antipsychotic-induced weight gain

(2007) G.D. Cooper et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY